Pan‐Chyr Yang - Concepedia

Author

Pan‐Chyr Yang

National Taiwan University Hospital ORCID

Also Known As

Bastow, Kenneth F., Gee‐Chen Chang, John Wong, Jyh-Yuan Yang, Jyh–Yuan Yang, Lin, Jau-Chen, Linda Rieswijk, Mei‐Huei Chen, Nakagawa-Goto, Kyoko, P C YANG

1.4K

Publications

62.8K

Citations

121

H-Index

413

Concepts

All Affiliations

National Taiwan University Hospital National Taiwan University Institute of Biomedical Sciences, Academia Sinica National Yang Ming Chiao Tung University Taichung Veterans General Hospital

About

Pan‐Chyr Yang is an author at National Taiwan University Hospital specializing in medicine, lung cancer, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	83	291	24.5K
2	Health Sciences	39	57	5.5K
3	Engineering	21	31	3K
4	Natural Sciences	10	10	798
5	Language Studies	1	1	20

Pan‐Chyr Yang

620

Publications

51.5K

Citations

115

H-Index

Page 1

	Year	Citations
<i>MET</i> amplification occurs with or without <i>T790M</i> mutations in <i>EGFR</i> mutant lung tumors with acquired resistance to gefitinib or erlotinib James Bean, Cameron Brennan, Jin‐Yuan Shih, Proceedings of the National Academy of Sciences Harbors Met AmplificationEngineeringPathologyTumor BiologyOncology	2007	1.6K
A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER) Yuankai Shi, Joseph S. K. Au, Sumitra Thongprasert, Journal of Thoracic Oncology	2014	1.5K
A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer Hsuan‐Yu Chen, Sung‐Liang Yu, Chun‐Houh Chen, New England Journal of Medicine	2007	947
MicroRNA Signature Predicts Survival and Relapse in Lung Cancer Sung‐Liang Yu, Hsuan‐Yu Chen, Gee‐Chen Chang, Cancer Cell MedicinePathologyCancer GenomicsSmall RnaLung Cancer	2008	781
Value of sonography in determining the nature of pleural effusion: analysis of 320 cases. Pan‐Chyr Yang, K T Luh, D B Chang, American Journal of Roentgenology Pleural BiopsyImaging AnatomyPleural EffusionsMedical UltrasoundMedical Imaging	1992	531
Pretreatment Epidermal Growth Factor Receptor ( <i>EGFR</i> ) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer Kang‐Yi Su, Hsuan‐Yu Chen, Ker-Chau Li, Journal of Clinical Oncology	2012	489
p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug Shu Ping Wang, Wen-Lung Wang, Yih‐Leong Chang, Nature Cell Biology Mdm2-mediated DegradationMedicineCell DeathAnti-cancer AgentTumor Suppressor	2009	482
Effectiveness of Tyrosine Kinase Inhibitors on “Uncommon” Epidermal Growth Factor Receptor Mutations of Unknown Clinical Significance in Non–Small Cell Lung Cancer Jenn‐Yu Wu, Chong‐Jen Yu, Yeun‐Chung Chang, Clinical Cancer Research	2011	461
Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling Wan-Jiun Chen, Chao‐Chi Ho, Yih‐Leong Chang, Nature Communications Lineage PlasticityParacrine SignallingMedicineCell PlasticityCancer-associated Fibroblasts	2014	438
Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications Jin‐Chuan Sheu, Juei‐Low Sung, Ding‐Shinn Chen, Gastroenterology HepatologyGrowth RateLiver PhysiologyMedicineHistopathology	1985	429

Page 1